CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 21h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter ended June 30, 2024, and provided a business update.
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
14 août 2024 16h30 HE
|
Biofrontera Inc.
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...
Fundamental Global Inc. Reports Second Quarter 2024 Financial Results
14 août 2024 16h15 HE
|
Fundamental Global Inc.
Mooresville, NC, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF, FGPP) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc. (“FG Financial”),...
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
14 août 2024 16h05 HE
|
GT Biopharma, Inc.
GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025GTB-5550 TriKE® IND submission for treatment of B7H3 positive solid tumors expected in 1H...
Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update
14 août 2024 16h01 HE
|
Celcuity Inc.
Announced plan to initiate Phase 3 VIKTORIA-2 trial evaluating gedatolisib combined with fulvestrant plus a CDK4/6 inhibitor as first-line treatment for patients with HR+, HER2- advanced breast...
Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 16h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter ended June 30, 2024, and provided a business update.
Digital Brands Group to Report Second Quarter 2024 Financial Results on Monday, August 19, 2024
14 août 2024 10h00 HE
|
Digital Brands Group, Inc.
Austin, TX, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (“DBG”) (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, will report financial results for the...
GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
14 août 2024 08h05 HE
|
GRI Bio, Inc.
Company focused on execution of lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) GRI-0621 interim data readout of Phase 2a biomarker study on track for Q4 2024 and...
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
14 août 2024 08h00 HE
|
ProPhase Labs, Inc.
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun in Q3 2024 and Potential Sale of Business ...
Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
14 août 2024 08h00 HE
|
Cocrystal Pharma, Inc.
Expects to report topline results in 2025 from Phase 2a influenza A human challenge study with oral CC-42344, including initial indication of virologyIn vitro testing shows CC-42344 inhibits the avian...